MyMD Pharmaceuticals Inc Stock price
Is MyMD Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
MyMD Pharmaceuticals Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a MyMD Pharmaceuticals Inc forecast:
Analyst Opinions
7 Analysts have issued a MyMD Pharmaceuticals Inc forecast:
Don't miss a Thing! We will send you all news about MyMD Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
MyMD Pharmaceuticals, Inc. is a clinical stage pharmaceutical company which engages in extending healthy lifespan. It involves in developing and commercializing therapeutic platforms based on well-defined therapeutic targets, MYMD-1 and Supera-CBD. The company is headquartered in Baltimore, MD.
| Head office | United States |
| CEO | Christopher Chapman |
| Founded | 1989 |
| Website | tnfpharma.com |


